Anti-BACH1/BRIP1 antibody (ab49657)
- Product nameAnti-BACH1/BRIP1 antibodySee all BACH1/BRIP1 primary antibodies ...
- DescriptionRabbit polyclonal to BACH1/BRIP1
- Tested applicationsWB, IP, ICC/IF more details
- Species reactivityReacts with: Mouse, Rat, Human
Synthetic peptide: NFKPSPSKNKGMFPGFK conjugated to KLH by a N terminal Cysteine residue linker, corresponding to amino acids 1233-1249 of Human BACH1/BRIP1
- Positive controlWhole extract of human MCF-7 cells, whole extracts of mouse NIH-3T3 and rat PC12 cells and RIPA extract of human HeLa cells.
- Storage instructionsStore at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
- Storage bufferPreservative: 15mM Sodium Azide
Constituents: 0.01M PBS, pH 7.4
- Concentration information loading...
- PurityImmunogen affinity purified
- Clonality Polyclonal
- Research Areas
Our Abpromise guarantee covers the use of ab49657 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||WB: Use a concentration of 0.1 - 1 µg/ml. Predicted molecular weight: 150 kDa.|
|IP||IP: Use a concentration of 1 - 10 µg/ml.|
|ICC/IF||ICC/IF: Use a concentration of 10 - 20 µg/ml.|
- FunctionDNA-dependent ATPase and 5' to 3' DNA helicase required for the maintenance of chromosomal stability. Acts late in the Fanconi anemia pathway, after FANCD2 ubiquitination. Involved in the repair of DNA double-strand breaks by homologous recombination in a manner that depends on its association with BRCA1.
- Tissue specificityUbiquitously expressed, with highest levels in testis.
- Involvement in diseaseDefects in BRIP1 are a cause of susceptibility to breast cancer (BC) [MIM:114480]. A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.
Defects in BRIP1 are the cause of Fanconi anemia complementation group J (FANCJ) [MIM:609054]. It is a disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.
- Sequence similaritiesBelongs to the DEAD box helicase family. DEAH subfamily.
Contains 1 helicase ATP-binding domain.
- Domain4Fe-4S iron-sulfur-binding is required for helicase activity (PubMed:20639400).
modificationsPhosphorylated. Phosphorylation is necessary for interaction with BRCA1, and is cell-cycle regulated.
- Cellular localizationNucleus.
- ATP dependent RNA helicase BRIP1 antibodyATP-dependent RNA helicase BRIP1 antibodyBACH 1 antibody
- BRAC 1 Associated C Terminal Helicase 1 antibodyBRCA 1 Interacting Protein 1 antibodyBRCA1 binding helicase like protein BACH1 antibodyBRCA1 interacting protein C terminal helicase 1 antibodyBRCA1-associated C-terminal helicase 1 antibodyBRCA1-interacting protein 1 antibodyBRCA1-interacting protein C-terminal helicase 1 antibodyBRCA1/BRCA2 associated helicase 1 antibodyBRIP 1 antibodyBRIP1 antibodyFANCJ antibodyFANCJ_HUMAN antibodyFanconi anemia group J protein antibodyFLJ90232 antibodyMGC126521 antibodyMGC126523 antibodyOF antibodyProtein FACJ antibody
References for Anti-BACH1/BRIP1 antibody (ab49657)
ab49657 has not yet been referenced specifically in any publications.